A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR UNTREATED PATIENTS WITH EXTENSIVE-DIASESE SMALL CELL LUNG CANCER

被引：0
|
作者：
Motoshima, Kohei [1 ]
Ogawara, Daiki [1 ]
Takemoto, Shinnosuke [1 ]
Mizoguchi, Kosuke [1 ]
Ikeda, Takaya [2 ]
Fukuda, Minoru [3 ]
Nakatomi, Katsumi [1 ]
Nagashima, Seiji [1 ]
Nakamura, Yoichi [1 ]
Kono, Shigeru [1 ]
机构：
[1] Nagasaki Univ, Dept Internal Med 2, Nagasaki, Japan
[2] Sasebo City Gen Hosp, Sasebo, Japan
[3] Japanese Red Cross Nagasaki Genbakul Hosp, Nagasaki, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu435.100
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O3-3-1
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive stage small cell lung cancer (ED-SCLC) (final report).
    Ohe, Y
    Negoro, S
    Matsui, K
    Nakagawa, K
    Sugiura, T
    Takada, Y
    Nishiwaki, Y
    Saijo, N
    Fukuoka, M
    Ariyoshi, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 667S - 667S
  • [32] Final result of phase II study of amrubicin (AMR) combined with carboplatin (CBDCA) for elderly patients with small cell lung cancer (SCLC)
    Ishimoto, O.
    Inoue, A.
    Sugawara, S.
    Harada, M.
    Usui, K.
    Suzuki, T.
    Yokouchi, H.
    Maemondo, M.
    Nukiwa, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer
    A Kinoshita
    M Fukuda
    H Soda
    S Nagashima
    M Fukuda
    H Takatani
    M Kuba
    Y Nakamura
    J Tsurutani
    S Kohno
    M Oka
    British Journal of Cancer, 2006, 94 : 1267 - 1271
  • [34] A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0405
    Inoue, A.
    Ishimoto, O.
    Fukumoto, S.
    Usui, K.
    Suzuki, T.
    Yokouchi, H.
    Maemondo, M.
    Kanbe, M.
    Ogura, S.
    Harada, T.
    Oizumi, S.
    Harada, M.
    Sugawara, S.
    Fukuhara, T.
    Nukiwa, T.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 800 - 803
  • [35] Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer
    Kinoshita, A
    Fukuda, M
    Soda, H
    Nagashima, S
    Fukuda, M
    Takatani, H
    Kuba, M
    Nakamura, Y
    Tsurutani, J
    Kohno, S
    Oka, M
    BRITISH JOURNAL OF CANCER, 2006, 94 (09) : 1267 - 1271
  • [36] Phase II study of nedaplatin plus amrubicin in patients with untreated, advanced or relapsed squamous cell lung cancer
    Suyama, T.
    Taniguchi, H.
    Ikeda, T.
    Yamaguchi, H.
    Kitazaki, T.
    Soda, H.
    Nakatomi, K.
    Kinosita, A.
    Fukuda, M.
    Mukae, H.
    ANNALS OF ONCOLOGY, 2018, 29 : 154 - 154
  • [37] Phase II trial with carboplatin and bendamustine in patients with extensive stage small-cell lung cancer
    Koester, Wolf
    Heider, Andrea
    Niederle, Norbert
    Wilke, Hansjochen
    Stamatis, Georgios
    Fischer, Juergen R.
    Koch, Jens A.
    Stahl, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (04) : 312 - 316
  • [38] Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancer
    Riedel, Richard F.
    Crawford, Jeffrey
    Dunphy, Frank
    Herndon, James E., II
    Garst, Jennifer
    Kelley, Michael J.
    LUNG CANCER, 2006, 54 (03) : 431 - 432
  • [39] PHASE I/II STUDY OF AMRUBICIN COMBINED WITH NEDAPLATIN (CDGP) IN UNTREATED NON-SMALL-CELL LUNG CANCER
    Nakamura, Yoichi
    Ogawara, Daiki
    Senju, Hiroshi
    Fukuda, Minoru
    Nakano, Hirofumi
    Ikeda, Takaya
    Nakatomi, Katsumi
    Iida, Tetsuya
    Nagashima, Seiji
    Kohno, Shigeru
    RESPIROLOGY, 2013, 18 : 1 - 1
  • [40] PHASE I/II STUDY OF AMRUBICIN COMBINED WITH NEDAPLATIN (CDGP) IN UNTREATED NON-SMALL-CELL LUNG CANCER
    Ogawara, D.
    Nakamura, Y.
    Fukuda, M.
    Nakatomi, K.
    Doi, S.
    Nakano, H.
    Motoshima, K.
    Senjyu, H.
    Iida, T.
    Kohno, S.
    ANNALS OF ONCOLOGY, 2013, 24
12345